BRIEF published on 08/06/2026 at 07:45, 1 month 30 days ago Leifheit AG publie ses résultats du premier semestre 2026, axés sur la compétitivité. Rentabilité Leifheit AG Compétitivité Programme FOCUS Résultats Financiers 2026
BRIEF published on 08/06/2026 at 07:38, 1 month 30 days ago 1&1 Reports Half-Year Financial Performance Revenue Growth Financial Forecast EBITDA Increase Customer Contracts 1&1 AG Results
BRIEF published on 08/06/2026 at 07:38, 1 month 30 days ago 1&1 publie ses résultats financiers du premier semestre Prévisions Financières Croissance Des Revenus Augmentation De L'EBITDA Contrats Clients Résultats De 1&1 AG
BRIEF published on 08/06/2026 at 07:36, 1 month 30 days ago Henkel Reports Strong First Half Performance and Upgrades 2026 Outlook Sales Growth M&A Strategy Earnings Henkel 2026 Forecast
BRIEF published on 08/06/2026 at 07:36, 1 month 30 days ago Henkel annonce de solides résultats au premier semestre et revoit à la hausse ses perspectives pour 2026. Croissance Des Ventes Henkel Gains Stratégie De Fusions Et Acquisitions Prévisions Pour 2026
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Nordex Group Secures Significant 525 MW Order in Türkiye Renewable Energy Nordex Group Wind Turbines Türkiye Market Türkerler Holding
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Le groupe Nordex obtient une commande importante de 525 MW en Turquie Énergie Renouvelable Groupe Nordex Éoliennes Marché Turc Türkerler Holding
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Evotec and Odyssey Therapeutics Join Forces in AI-Driven Drug Discovery Evotec SE Inflammatory Diseases Autoimmune Diseases Odyssey Therapeutics AI-driven Discovery
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Evotec et Odyssey Therapeutics unissent leurs forces dans la découverte de médicaments guidée par l'IA Evotec SE Maladies Inflammatoires Maladies Auto-immunes Odyssey Therapeutics Découverte Pilotée Par L'IA
BRIEF published on 08/06/2026 at 07:35, 1 month 30 days ago Evotec and Odyssey Therapeutics Form AI-Driven R&D Partnership Drug Discovery Autoimmune Diseases Milestone Payments Evotec Collaboration AI-driven R&D
Published on 10/05/2026 at 14:45, 47 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 1 hour 2 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 1 hour 2 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 1 hour 32 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 1 hour 32 minutes ago GameSquare to Present at Upcoming Investor Conferences
Published on 10/05/2026 at 15:28, 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group PLC
Published on 10/05/2026 at 15:24, 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/05/2026 at 15:00, 32 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 10/05/2026 at 15:00, 32 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 10/05/2026 at 13:09, 2 hours 23 minutes ago 261005 BENETEAU Transactions sur actions propres
Published on 10/05/2026 at 11:15, 4 hours 17 minutes ago Statement of transactions in own shares from September 28, 2026 to October 2, 2026
Published on 10/05/2026 at 11:15, 4 hours 17 minutes ago Déclaration des transactions sur actions propres réalisées du 28/09/2026 au 02/10/2026
